Literature DB >> 30121821

Molecular dynamics simulation as a tool for assessment of drug binding property of human serum albumin.

Meenu Narwal1, Deepak Kumar2, Tapan Kumar Mukherjee1, Rajasri Bhattacharyya3, Dibyajyoti Banerjee4.   

Abstract

Human serum albumin (HSA) is a major plasma protein and binding of drugs with this plasma protein has a great importance. It possess esterase activity which can cleave the drugs containing ester bond and thus, can regulate the effect of drugs. Till date no systematic study has been done to analyse binding of such drugs and to compare the results with the drugs which do not have ester bond. Therefore, in the present study two different categories-ester and non-ester drugs have been considered to analyse their interaction with HSA at two principle drug binding sites using molecular modelling tools. It is observed that the drugs irrespective of ester or non-ester nature prefer either Sudlow site I or II by hydrogen bond and hydrophobic interactions. The information obtained from the study can assist to study pharmacokinetics of the drugs and that in turn will help in noval drug discoveries.

Entities:  

Keywords:  Drug–HSA interaction; Ester drug; Esterase activity; HSA; Non-ester drug

Mesh:

Substances:

Year:  2018        PMID: 30121821     DOI: 10.1007/s11033-018-4308-3

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  20 in total

1.  Probing the Sudlow binding site with warfarin: how does gold nanocluster growth alter human serum albumin?

Authors:  B A Russell; P A Mulheran; D J S Birch; Y Chen
Journal:  Phys Chem Chem Phys       Date:  2016-08-17       Impact factor: 3.676

2.  Crystal structure of human serum albumin at 2.5 A resolution.

Authors:  S Sugio; A Kashima; S Mochizuki; M Noda; K Kobayashi
Journal:  Protein Eng       Date:  1999-06

3.  Study of the interaction between DNP and DIDS with human hemoglobin as binary and ternary systems: spectroscopic and molecular modeling investigation.

Authors:  Shamim Rashidipour; Samane Naeeminejad; Jamshidkhan Chamani
Journal:  J Biomol Struct Dyn       Date:  2015-02-18

4.  Binding of the general anesthetics propofol and halothane to human serum albumin. High resolution crystal structures.

Authors:  A A Bhattacharya; S Curry; N P Franks
Journal:  J Biol Chem       Date:  2000-12-08       Impact factor: 5.157

5.  Crystal structure analysis of warfarin binding to human serum albumin: anatomy of drug site I.

Authors:  I Petitpas; A A Bhattacharya; S Twine; M East; S Curry
Journal:  J Biol Chem       Date:  2001-04-02       Impact factor: 5.157

6.  Comparative binding character of two general anaesthetics for sites on human serum albumin.

Authors:  Renyu Liu; Qingcheng Meng; Jin Xi; Jinsheng Yang; Chung-Eun Ha; Nadhipuram V Bhagavan; Roderic G Eckenhoff
Journal:  Biochem J       Date:  2004-05-15       Impact factor: 3.857

7.  Spectroscopic and DFT investigation of interactions between cyclophosphamide and aspirin with lysozyme as binary and ternary systems.

Authors:  Mohammad Reza Bozorgmehr; Jamshidkhan Chamani; Ghodsiye Moslehi
Journal:  J Biomol Struct Dyn       Date:  2014-10-10

8.  Long chain fatty acids alter the interactive binding of ligands to the two principal drug binding sites of human serum albumin.

Authors:  Keishi Yamasaki; Saya Hyodo; Kazuaki Taguchi; Koji Nishi; Noriyuki Yamaotsu; Shuichi Hirono; Victor Tuan Giam Chuang; Hakaru Seo; Toru Maruyama; Masaki Otagiri
Journal:  PLoS One       Date:  2017-06-29       Impact factor: 3.240

Review 9.  Interactive association of drugs binding to human serum albumin.

Authors:  Feng Yang; Yao Zhang; Hong Liang
Journal:  Int J Mol Sci       Date:  2014-02-27       Impact factor: 5.923

10.  Binding between Saikosaponin C and Human Serum Albumin by Fluorescence Spectroscopy and Molecular Docking.

Authors:  Yi-Cun Chen; Hong-Mei Wang; Qing-Xia Niu; Dan-Yan Ye; Guo-Wu Liang
Journal:  Molecules       Date:  2016-01-28       Impact factor: 4.411

View more
  1 in total

1.  In vitro and in vivo cytotoxic activity and human serum albumin interaction for a methoxy-styryl-thiosemicarbazone.

Authors:  Otávio Augusto Chaves; Isabela S de Castro; Carla Marins Goulart; Myrtes S S Bellieny; José Carlos Netto-Ferreira; Juliana Echevarria-Lima; Aurea Echevarria
Journal:  Invest New Drugs       Date:  2019-01-19       Impact factor: 3.850

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.